Consistently, CHD2 mutation is one of the most frequently reported genetic alterations in chronic lymphocytic leukaemia (CLL), indicating an additional role in lymphoid development [34]. This evidence concerns the gene CHD2 and B-cell chronic lymphocytic leukemia.